source
- CNS players discuss deals, psychiatry challenges and Alzheimer focus at Jefferies London conferenceThe Jefferies Global Healthcare conference in London brought together several companies active in the central nervous system and psychiatry sectors. Attendees heard updates from a range of drugmake…
- Neuroscience startups attract $450M in recent funding, Oyster Therapeutics secures $60M Series AVenture capital activity around neuroscience has picked up again, with five neurology-focused startups collectively raising about $450 million in the past few weeks. Data from BioPharma Dive show…